Matthew Pillar - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Matthew Pillar's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Matthew Pillar

Matthew Pillar

Verified

Chief Editor, Bioprocess Online

Erie, Horsham, Pittsburgh, United States

Final Covers

Bioprocessing , Biotechnology , Biopharmaceuticals , Biological Therapies

Doesn’t Cover

At present, I am no longer covering the retail or IT industries.

Journalist Type

Seniority Positions

Industries

-

Medium Formats

Content

Total articles 697

  • 02.21.25 -- Inside Interius' Global Regulatory Strategy

    By Matthew Pillar, Raul P. Lima, inSeption Group, Lakshmi Guduri| Cell & Gene Verified Join Cell & Gene Live for an exclusive look at cutting-edge manufacturing technologies revolutionizing cell therapy production. Our expert panel will explore organoids, 3D cultures, automation, and scalable solutions to streamline processes and enhance efficiency. Gain insights into the latest innovations driving the future of cell therapy. Registration is free thanks to the support of CPC and MaxCyte.

    By Matthew Pillar, Raul P. Lima, inSeption Group, Lakshmi Guduri · Cell & Gene

    Feb. 21, 2025

  • 02.08.25 -- Bioprocess Online Best Of January

    By Matthew Pillar, Infors Ht, Valentina Haag, Paulina Toboła| Bioprocess Online Verified JANUARY'S BEST FEATURED EDITORIALADCs: Leading With The LinkerLeo Marx, Ph.D., the Medicinal Chemistry Project and Bioconjugation Manager at Debiopharm, shares his company's rationale for the company's ADC development decisions and why its linker technology is the tip of the spear for those that make the cut.

    By Matthew Pillar, Infors Ht, Valentina Haag, Paulina Toboła · Bioprocess Online

    Feb. 08, 2025

  • 02.21.25 -- Inside Interius' Global Regulatory Strategy

    By Matthew Pillar, Raul P. Lima, inSeption Group, Lakshmi Guduri| Cell & Gene Verified Join Cell & Gene Live for an exclusive look at cutting-edge manufacturing technologies revolutionizing cell therapy production. Our expert panel will explore organoids, 3D cultures, automation, and scalable solutions to streamline processes and enhance efficiency. Gain insights into the latest innovations driving the future of cell therapy. Registration is free thanks to the support of CPC and MaxCyte.

    By Matthew Pillar, Raul P. Lima, inSeption Group, Lakshmi Guduri · Cell & Gene

    Feb. 21, 2025

As seen in

Company Info

Bioprocess Online